Topic resource collection
Approved comparison material connected to this topic.
479 resourcesRead both sides
Thymalin Thymic hormone restoration; stimulates T-cell maturation and thymulin production Increased CD4+/CD8+ counts, improved vaccine response, reduced infection rates in elderly subjects (clinical trials, St. Petersburg Institu…
GHK-Cu (Copper Peptide) Fibroblast activation, collagen/elastin gene upregulation, lysyl oxidase catalysis Type I/III collagen, elastin networks, decorin 1–3% in liposomal carrier 14.2% skin density increase in 12 weeks (J Drugs …
Thymalin (thymulin analog) Increases CD4+CD25+FoxP3+ Treg cells Restores T-cell balance away from TH2 dominance Preclinical murine models No Phase 3 human trials for allergy indications. Dosing protocols undefined KPV (Lys-Pro-Va…
This table compares the five peptides with the strongest preclinical and clinical evidence for neuropathic pain relief based on mechanism, onset, and research-demonstrated efficacy. BPC-157 VEGF upregulation, nitric oxide signali…
BPC-157 VEGF upregulation, angiogenesis, collagen alignment 200–500 mcg/day subcutaneous near injury site Subcutaneous, 2–3 inches from injury Reduces healing time by 30–40% in research models Best choice for acute ligament tears…
BPC-157 VEGF upregulation, nitric oxide synthesis Angiogenesis, gingival wound closure Strong preclinical (rat/dog models), no human RCTs for periodontitis 200–500 mcg SC or topical gel, 2–3× weekly Best evidence for direct vascu…
Thymalin T-cell regulation, cytokine modulation Neuroinflammation (IL-6, TNF-α) Subcutaneous 6–8 hours Best evidence for immune normalization in neuroimmune models; requires multi-week administration Cerebrolysin BDNF/NGF mimetic…
Cerebrolysin BDNF/NGF mimetic; enhances neurotrophic signaling in hippocampus and amygdala Yes (receptor-mediated transcytosis) 0.5–2.0 mL/kg IM daily × 10–21 days 40–60% increase in hippocampal BDNF mRNA; improved fear extinctio…
BPC-157 VEGF upregulation, NO pathway modulation, mucosal healing Accelerated colonic anastomosis healing, reduced inflammatory infiltrates in colitis models (Journal of Physiology-Paris) Intraperitoneal, oral, topical Limited hu…
Ibuprofen (NSAID) COX-1/COX-2 inhibition Prostaglandin synthesis blockade 30–60 minutes 1.8–2 hours Does not address uterine ischemia or smooth muscle dysfunction; gastrointestinal erosion risk with chronic use BPC-157 eNOS upreg…
BPC-157 VEGF receptor upregulation, NO synthesis, FAK-paxillin pathway activation 10–20mcg/kg daily (animal models) Subcutaneous injection Rodent studies, one small human case series Strong mechanistic rationale; human clinical d…
BPC-157 Upregulates VEGF; activates FAK-paxillin pathway for fibroblast migration 250–500mcg daily (subcutaneous) ~4 hours 40–60% faster collagen synthesis in controlled wound models (Journal of Tissue Engineering, 2023) Best for…
BPC-157 Upregulates VEGF and angiogenesis in hypoxic tissue; increases capillary density at injury site 200–500 mcg/day subcutaneous near injury site for 4–8 weeks Subcutaneous injection into thenar eminence or web space 3–4 week…
Thymalin Thymic immune regulation; modulates T-cell activity and suppresses inflammatory cytokines (IL-6, TNF-α) Observational study (St. Petersburg Institute). 30% cytokine reduction, 40–50% hot flash frequency reduction over 8 …
BPC-157 VEGF upregulation, angiogenesis Promotes new capillary formation in ischemic tissue. Addresses progressive microvascular damage Preclinical animal models; no human Raynaud's trials Requires daily subcutaneous injection; e…
BPC-157 VEGF upregulation, eNOS activation, endothelial repair 200–500 mcg/day subcutaneous 4–6 hours Preclinical animal models show 40% improvement in blood flow recovery vs controls Strongest mechanistic evidence for direct ang…
P21 BDNF upregulation, hippocampal neurogenesis No REM extension. Enhances consolidation efficiency during existing REM periods High. Improved narrative coherence and next-day recall without sleep fragmentation 10–20mg subcutaneo…
Before selecting a peptide protocol, understand what each compound does at the molecular level and how those mechanisms apply to fibrocartilage structure. BPC-157 VEGF upregulation, angiogenesis Extends vascular penetration into …
Thymalin Thymic immune modulation, cytokine regulation Reduces neuroinflammation driven by IL-6, TNF-alpha at trigeminal junction Animal models + immune disorder trials Requires reconstitution, subcutaneous injection, typically 5…
Thymosin Beta-4 (TB-4) Downregulates TGF-β1, inhibits mast cell degranulation, promotes organized angiogenesis Active (early-stage) Reduced keloid fibroblast proliferation by 40% at 100 μg/mL (Journal of Investigative Dermatology…